Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02479451 · ClinicalTrials.gov registry record · Phase 2
Helping Olfaction and Nutrition On Renal Replacement
A Phase 2 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT02479451: Completed Phase 2 study, sponsored by Massachusetts General Hospital.
NCT02479451 is a Phase 2 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02479451, a Phase 2 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.
Interventions
- DRUG Theophylline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-10 |
| Est. Completion | 2022-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02479451
The ClinicalTrials.gov registry entry for NCT02479451 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Theophylline is the first listed.
NCT02479451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02479451 about?
NCT02479451 is a clinical study titled "Helping Olfaction and Nutrition On Renal Replacement". This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.
What is the current status of trial NCT02479451?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2015-10. Estimated completion is 2022-07.
What interventions are being tested in trial NCT02479451?
The interventions under investigation include: Theophylline (DRUG).
Who is sponsoring clinical trial NCT02479451?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.